Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts

Diabetes Research and Clinical Practice

Volumn 87, Issue 3, 2010, Pages 385-393

  Caughey, Gillian E ^a   Roughead, Elizabeth E ^a   Vitry, Agnes I ^a   McDermott, Robyn A ^a   Shakib, Sepehr ^b   Gilbert, Andrew L ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Comorbidity; Diabetes; Elderly; Inappropriate prescribing; Polypharmacy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; AMIODARONE; AMITRIPTYLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; DOXEPIN; FLUNITRAZEPAM; GLIBENCLAMIDE; GLIMEPIRIDE; GLITAZONE DERIVATIVE; INDOMETACIN; INSULIN; METFORMIN; METHYLDOPA; NIFEDIPINE; NITRAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; SULFONAMIDE; UNINDEXED DRUG;

AGED; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DRUG SAFETY; FEMALE; GASTROESOPHAGEAL REFLUX; HEART FAILURE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; POLYPHARMACY; PRESCRIPTION; PREVALENCE; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; FEMALE; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PREVALENCE;

EID: 77649342075     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.10.019     Document Type: Article

References (46)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Wolff J.L., Starfield B., and Anderson G. Prevalence, Expenditures, and complications of multiple chronic conditions in the elderly. Arch. Intern. Med. 162 (2002) 2269-2276
3. Britt H.C., Harrison C.M., Miller G.C., and Knox S.A. Prevalence and patterns of multimorbidity in Australia. Med. J. Aust. 189 (2008) 72-77
4. Weiss C.O., Boyd C.M., Yu Q., Wolff J.L., and Leff B. Patterns of prevalent major chronic disease among older adults in the United States. JAMA 298 (2007) 1160-1162
5. Kerr E.A., Heisler M., Krein S.L., Kabeto M., Langa K.M., Weir D., et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management?. J. Gen. Intern. Med. 22 (2007) 1635-1640
6. Halanych J.H., Safford M.M., Keys W.C., Person S.D., Shikany J.M., Kim Y.-I., et al. Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 30 (2007) 2999-3004
7. Howard B.V., Best L.G., Galloway J.M., Howard W.J., Jones K., Lee E.T., et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29 (2006) 391-397
8. Piette J.D., and Kerr E.A. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29 (2006) 725-731
9. Durso S.C. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 295 (2006) 1935-1940
10. California Healthcare Foundation/American Geriatrics Society Panel in Improving Care for Elders with Diabetes, Guidelines for improving the care of the older person with diabetes mellitus, J. Am. Geriatr. Soc. 51 (2003) 265-280.
11. Ciechanowski P.S., Katon W.J., and Russo J.E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med. 160 (2000) 3278-3285
12. Miksch A., Hermann K., Rolz A., Joos S., Szecsenyi J., Ose D., et al. Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany-a cross-sectional survey. Health Qual Life Outcomes 7 (2009) 19
13. Rollason V., and Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 20 (2003) 817-832
14. Milton J.C., Hill-Smith I., and Jackson S.H. Prescribing for older people. BMJ 336 (2008) 606-609
15. World Health Organization International Classification of Diseases, International Statistical Classification of Diseases and Related Health Problems, 10th revision, vol. 2008, 2007.
16. Australian Government Department of Health and Ageing, Schedule of pharmaceutical benefits. PBS for Health Professionals, http://www.pbs.gov.au/html/healthpro/home (accessed August 2008), 2008.
17. Australian Bureau of Statistics, 2001 Census of Population and Housing-SEIFA 2001, 2001.
18. Australian Centre for Diabetes Strategies, For the Diabetes Australia Guideline Development Consortium. National evidence based guidelines for the management of type 2 diabetes mellitus, http://www.nhmrc.gov.au/publications/synopses/di7todi13syn.htm (accessed Jan 2009). National Health and Medical Research Council: Canberra, Australia 2005.
19. Vitry A.I., Wong S.A., Roughead E.E., Ramsay E., and Barratt J. Validity of medication-based comorbidity indices in the Australian elderly population Australian and New Zealand. J. Public Health 33 (2009) 126-130
20. Caughey G.E., Vitry A.I., Gilbert A.L., and Roughead E.E. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health 8 (2008) 221-233
21. Endocrinology Expert Group. Therapeutic Guidelines: Endocrinology, Version 5 (2004), Therapeutic Guidelines Limited, Victoria, Australia
22. Australian Medicines Handbook. Australian Medicines Handbook (2009), Australian Medicines Handbook Pty. Ltd.
23. Nisbet J.C., Sturtevant J.M., and Prins J.B. Metformin and serious adverse effects. MJA 180 (2004) 53-54
24. Graal M.B., and Wolffenbuttel B.H. The use of sulphonylureas in the elderly. Drugs Aging 15 (1999) 471-481
25. Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med. 351 (2004) 1106-1118
26. van der Woude H.J., Zaagsma J., Postma D.S., Winter T.H., van Hulst M., and Aalbers R. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest 127 (2005) 818-824
27. Michael J., Abramson, Alan J.C., Peter A., Frith, Christine F., et al. COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. MJA 184 (2006) 342-345
28. Slatore C.G., Bryson C.L., and Au D.H. The association of inhaled corticosteroid use with serum glucose concentrations in a large cohort. Am. J. Med. 122 (2009) 472-478
29. Consuelo Huerta, Jordi Castellsague, Cristina Varas-Lorenzo, and Luis Alberto GarcÃa RodrÃguez. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am. J. Kidney Dis. 45 (2005) 531-539
30. Roughead E.E., Ramsay E., Pratt N., and Gilbert A.L. NSAID use in individuals at risk of renal adverse events: an observational study to investigate trends in Australian veterans. Drug Saf. 31 (2008) 997-1003
31. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch. Intern. Med. 157 (1997) 1531-1536
32. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean J.R., and Beers M.H. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med. 163 (2003) 2716-2724
33. Pogach L.M., Tiwari A., Maney M., Rajan M., Miller D.R., and Aron D. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?. Am. J. Manag. Care 13 (2007) 133-140
34. Salpeter S.R., Greyber E., Pasternak G.A., and Salpeter E.E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch, Intern. Med. 163 (2003) 2594-2602
35. Page J., and Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch. Intern. Med. 160 (2000) 777-784
36. Garcia Rodríguez L.A., and Hernández-Díaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res. 3 (2001) 98-101
37. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176 (2007) 532-555
38. Ray K.K., Seshasai S.R.K., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. The Lancet 373 (2009) 1765-1772
39. Erdmann E. Safety and tolerability of beta-blockers: prejudices and reality. Eur. Heart J. Suppl. 11 (2009) A21-25
40. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardioselective β-blockers in patients with reactive airway disease: a meta-analysis. Ann. Intern. Med. 137 (2002) 715-725
41. Dransfield M.T., Rowe S.M., Johnson J.E., Bailey W.C., and Gerald L.B. Use of {beta} blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 63 (2008) 301-305
42. Roughead EE, Anderson B, Gilbert AL. Potentially inappropriate prescribing amongst Australian veterans and war widows/widowers. IMJ.
43. van der Hooft C.S., Jong G.W., Dieleman J.P., Verhamme K.M., van der Cammen T.J., Stricker B.H., et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria-a population-based cohort study. Br. Clin. Pharm. 60 (2005) 137-144
44. Jano E., and Aparasu R.R. Healthcare outcomes associated with Beers' criteria: a systematic review. Ann. Pharmacother. 41 (2007) 438-447
45. Budnitz D.S., Shehab N., Kegler S.R., and Richards C.L. Medication use leading to emergency department visits for adverse drug events in older adults. Ann. Intern. Med. 147 (2007) 755-765
46. Steinman M.A., Rosenthal G.E., Landefeld C.S., Bertenthal D., and Kaboli P.J. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch. Intern. Med. 169 (2009) 1326-1332